1.上海中医药大学附属曙光医院肺病科(上海 201203)
2.复旦大学附属华东医院呼吸科(上海 200040)
3.上海市长宁区天山中医医院治未病科(上海 200051)
陈麒,男,博士,副主任医师,主要从事中医药防治呼吸系统疾病的临床与基础研究
唐中豪,副主任医师;E-mail:tangzhww@163.com。
孟令一,副主任医师;E-mail:menglingyidoctor@126.com
扫 描 看 全 文
陈麒, 唐中豪, 孟令一, 等. 基于综合肺康复管理的改良中医呼吸导引技术对南疆地区COPD稳定期患者的疗效评价[J]. 上海中医药大学学报, 2021,35(3):33-38.
CHEN Qi, TANG Zhonghao, MENG Lingyi, et al. Efficacy evaluation of improved TCM respiratory guidance technology based on comprehensive pulmonary rehabilitation management in treating patients with COPD at stable stage in southern Xinjiang[J]. Academic Journal of Shanghai University of Traditional Chinese Medicine, 2021,35(3):33-38.
陈麒, 唐中豪, 孟令一, 等. 基于综合肺康复管理的改良中医呼吸导引技术对南疆地区COPD稳定期患者的疗效评价[J]. 上海中医药大学学报, 2021,35(3):33-38. DOI: 10.16306/j.1008-861x.2021.03.007.
CHEN Qi, TANG Zhonghao, MENG Lingyi, et al. Efficacy evaluation of improved TCM respiratory guidance technology based on comprehensive pulmonary rehabilitation management in treating patients with COPD at stable stage in southern Xinjiang[J]. Academic Journal of Shanghai University of Traditional Chinese Medicine, 2021,35(3):33-38. DOI: 10.16306/j.1008-861x.2021.03.007.
目的:,2,观察基于综合肺康复管理的改良中医呼吸导引技术对南疆地区慢性阻塞性肺疾病(COPD)稳定期患者的临床疗效。,方法:,2,选取南疆地区COPD稳定期患者100例,随机分为治疗组和对照组,每组各50例。两组患者均给予西医常规基础治疗,同时配合综合肺康复管理,对照组患者的综合肺康复管理采用缩唇腹式呼吸训练,而治疗组患者采用改良中医呼吸导引技术训练。两组患者的治疗周期均为6个月,随访周期为6个月。治疗前后,评估两组患者的主要症状积分;检测两组患者的主要肺通气功能指标,包括第1秒用力呼气容积占预计值百分比(FEV,1,%)、第1秒用力呼气容积(FEV,1,)/用力肺活量(FVC)、最大呼气流量占正常预计值百分比(PEF%);采用COPD评估测试(CAT)评分评价患者的生活质量;采用6 min步行距离(6MWD)和Borg评分评估两组患者的运动能力及呼吸困难程度;采用汉密尔顿抑郁量表(HAMD)、汉密尔顿焦虑量表(HAMA)评分评价患者的心理健康状况;统计并比较两组患者在治疗1年内的急性发作住院例次、平均每次住院天数和住院总费用。,结果:,2,试验过程中,治疗组1例患者、对照组1例患者被剔除,最终治疗组49例、对照组49例纳入统计分析。①治疗后,两组患者的主要症状积分较治疗前均明显降低(,P,<,0.05,,P,<,0.01),且治疗组患者的积分低于对照组(,P,<,0.05)。②治疗后,治疗组患者的FEV,1,%、PEF%水平较治疗前升高(,P,<,0.05),且治疗组患者的FEV,1,%、PEF%水平高于对照组(,P,<,0.05)。③治疗后,两组患者的CAT评分较治疗前均显著降低(,P,<,0.05,,P,<,0.01),且治疗组患者的评分低于对照组(,P,<,0.05)。④治疗后,治疗组患者的6MWD较治疗前明显延长、Borg评分较治疗前显著降低(,P,<,0.05,,P,<,0.01),且治疗组患者的6MWD长于对照组、Borg评分低于对照组(,P,<,0.05)。⑤治疗后,治疗组患者的HAMD、HAMA评分较治疗前均显著降低(,P,<,0.01),对照组患者的HAMA评分较治疗前亦降低(,P,<,0.05),且治疗组患者的HAMD、HAMA评分均低于对照组(,P,<,0.05)。⑥在1年观察期间,与对照组患者相比,治疗组患者的急性发作住院例次明显减少、每次住院时间明显缩短、住院总费用明显降低(,P,<,0.05,,P,<,0.01)。,结论:,2,基于综合肺康复管理的改良中医呼吸导引技术能有效改善南疆地区COPD稳定期患者的临床症状,增强其肺功能,提高生活质量,同时减轻患者的经济负担。
Objective:,2,To observe the clinical efficacy of improved TCM respiratory guidance technology based on comprehensive pulmonary rehabilitation management in treating patients with chronic obstructive pulmonary disease(COPD) at stable stage in southern Xinjiang.,Methods:,2,A total of 100 patients with COPD at stable stage in southern Xinjiang were selected and randomly divided into the treatment group and control group, 50 cases in each group.The patients in both groups were treated with conventional western medicine, meanwhile combined with comprehensive pulmonary rehabilitation management.In comprehensive pulmonary rehabilitation management, the contracted lip-abdominal breathing training was applied for patients in the control group, and the improved TCM respiratory guidance technology training was applied for patients in the treatment group.The treatment course of both groups was 6 months, and the follow-up course was 6 months.Before and after treatment, the score of main symptoms was evaluated in both groups, and the main indexes of pulmonary ventilation function were detected, including forced expiratory volume in one second as a percentage of predicted volume(FEV,1,%), ratio of forced expiratory volume in one second(FEV,1,) to forced vital capacity(FVC) and peak expiratory flow as a percentage of predicted volume(PEF%) .The quality of life was evaluated by the score of COPD assessment test(CAT) .The motor ability and the dyspnea degree were evaluated by 6-minute walking distance(6MWD) and Borg score.The mental health was evaluated by Hamilton depression scale(HAMD) and Hamilton anxiety scale(HAMA) .Within one year of intervention, the number of acute attack hospitalization, the average hospitalization days and the total hospitalization cost were calculated and compared in both groups.,Results:,2,In the course of trial, one patient in the treatment group and one patient in the control group were excluded, finally 49 cases in the treatment group and 49 cases in the control group were included for statistical analysis.①After treatment, the score of main symptoms in both groups was significantly decreased compared with that before treatment(,P,<,0.05,P,<,0.01), and the score of the treatment group was lower than that of the control group(,P,<,0.05) .②After treatment, the levels of FEV,1,% and PEF% in the treatment group were increased compared with those before treatment(,P,<,0.05), and the levels of FEV,1,% and PEF% in the treatment group were higher than those in the control group(,P,<,0.05) .③After treatment, the CAT score in both groups was significantly decreased compared with that before treatment(,P,<,0.05,P,<,0.01), and the score of the treatment group was lower than that of the control group(,P,<,0.05) .④After treatment, the 6MWD was significantly prolonged and the Borg score was significantly decreased in the treatment group compared with those before treatment(,P,<,0.05,P,<,0.01), and the 6MWD of the treatment group was longer than that of the control group and the Borg score was lower than that of the control group(,P,<,0.05) .⑤After treatment, the scores of HAMD and HAMA in the treatment group were significantly decreased compared with those before treatment(,P,<,0.01), the score of HAMA in the control group was also decreased compared with that before treatment(,P,<,0.05), and the scores of HAMD and HAMA in the treatment group were lower than those in the control group(,P,<,0.05) .⑥During the one-year observation period, compared with the control group, the number of acute attack hospitalization was significantly reduced in the treatment group, the average hospitalization days were significantly shortened, and the total hospitalization cost was significantly decreased(,P,<,0.05,P,<,0.01) .,Conclusion:,2,The improved TCM respiratory guidance technology based on comprehensive pulmonary rehabilitation management can effectively improve the clinical symptoms of COPD patients at stable stage in southern Xinjiang, enhance the pulmonary function, improve the quality of life, meanwhile reduce the economic burden.
慢性阻塞性肺疾病(COPD)稳定期综合肺康复管理改良中医呼吸导引技术
chronic obstructive pulmonary disease (COPD)stable stagecomprehensive pulmonary rehabilitation managementimproved TCM respiratory guidance technology
陈亚红.2018年GOLD慢性阻塞性肺疾病诊断、治疗及预防全球策略解读[J].中国医学前沿杂志(电子版),2017,9(12):15-22.
加孜那·托哈依,胡晓婷,赵双锁,等.新疆和田农村地区60岁以上维吾尔族人群慢性阻塞性肺疾病的流行病学调查[J].新疆医科大学学报,2010,33(9):1017-1020.
陈麒,田君,蒋骏,等.改良中医呼吸导引康复技术治疗慢性阻塞性肺疾病稳定期患者的临床观察[J].上海中医药大学学报,2017,31(3):33-39.
吴文辉,何珂,包江波,等.喀什地区卫生发展与上海卫生援疆的实践[J].中国卫生资源,2014,17(1):23-25.
中华医学会呼吸病学分会慢性阻塞性肺疾病学组.慢性阻塞性肺疾病诊治指南(2013年修订版)[J].中华结核和呼吸杂志,2013,36(4):255-264.
郑筱萸.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002.
JONES P W,TABBERER M,CHEN W H. Creating scenarios of the impact of COPD and their relationship to COPD Assessment Test(CATTM)scores[J]. BMC Pulm Med,2011,11:42.
钟义华,温月秀,易娜,等.改良步行试验与6分钟步行试验在中重度COPD稳定期患者中的应用效果比较[J].中国当代医药,2019,26(27):61-63.
张作记.行为医学量表手册[M].北京:中华医学电子音像出版社,2005.
秦国双,温昊于,宇传华.中国COPD的患病发病及YLD现状及趋势[J].公共卫生与预防医学,2019,30(2):4-8.
杨金红.新疆南疆地区COPD发病现状[J].中国社区医师,2012,14(14):392.
SPRUIT M A,SINGH S J,GARVEY C,et al. An official American Thoracic Society/European Respiratory Society statement:key concepts and advances in pulmonary rehabilitation[J]. Am J Respir Crit Care Med,2013,188(8):e13-e64.
0
浏览量
284
下载量
0
CSCD
6
CNKI被引量
关联资源
相关文章
相关作者
相关机构